SUZANNE ADLER: Open Payments
NPI 1386991453 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,918 in 92 payments from 15 companies in 2025. Trend: 2023 $810 · 2024 $1,541 · 2025 $1,918
Food & beverage: $1,843Education: $75
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $334 |
| Novartis Pharmaceuticals Corporation | 17 | $287 |
| Janssen Biotech, Inc. | 14 | $246 |
| Incyte Corporation | 7 | $165 |
| GENZYME CORPORATION | 4 | $152 |
| Botanix SB Inc | 2 | $115 |
| Galderma Laboratories, L.P. | 5 | $92 |
| Organon LLC | 8 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
Products named: Bimzelx, TREMFYA, COSENTYX, DUPIXENT, OPZELURA, SOFDRA, SPEVIGO, Sotyktu.
Industry payments across MD — which companies pay providers there.
